CD4 and neoplasm: In 2024, Cardenas et al. [67] published an article in Nature that showed that the differentiation of stem-like CD4+ T cells in TDLNs was a major factor in the growth of tumor cells, with Treg in TDLNs being more prone to producing TGF-β compared to effector CD4+ T cells.